COMMUNIQUÉS West-GlobeNewswire
-
Royal Columbian Hospital Foundation unveils the Jack & Sylvia Gin Emergency & Trauma Imaging Centre (GinETIC)
29/04/2026 -
EUROBIO SCIENTIFIC : Rapport Financier Annuel 2025
29/04/2026 -
Cristcot to Present Oral Abstract at 2026 Digestive Disease Week (DDW)
29/04/2026 -
Carbios files its 2025 Universal Registration Document
29/04/2026 -
Press Release: Annual General Meeting of April 29, 2026 - Belén Garijo appointed as Director and Chief Executive Officer of Sanofi
29/04/2026 -
EHS Opens Walsh Ambulatory Pavilion, Expanding Access to Advanced Outpatient Care
29/04/2026 -
NADP advocates greater access to care through dental coverage
29/04/2026 -
U.S. News & World Report Announces "Best of" 2026 Ratings for Legend Senior Living® Residences
29/04/2026 -
EUROBIO SCIENTIFIC : MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025
29/04/2026 -
FDA Releases Results from Largest-Ever Testing of Infant Formula in the U.S.
29/04/2026 -
Syncromune®, Inc. Presents Innovative SYNC-T™ Combination Immunotherapy Approach at Major European Interventional Oncology Conference
29/04/2026 -
Modalité de mise à disposition des documents préparatoires à l'AG 2026
29/04/2026 -
Beacon Therapeutics Announces Presentations at the ARVO 2026 Annual Meeting
29/04/2026 -
CARBIOS annonce la mise à disposition de son Document d’enregistrement universel 2025
29/04/2026 -
Communiqué de presse : Assemblée Générale Annuelle du 29 avril 2026 - Belén Garijo nommée administratrice et Directrice générale de Sanofi
29/04/2026 -
Availabilty of 2026 AGM preparatory documents
29/04/2026 -
RenovoRx to Host First Quarter 2026 Financial Results and Business Highlights Conference Call on May 14th at 4:30 pm ET
29/04/2026 -
XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies
29/04/2026 -
Codexis to share RNA manufacturing advances at TIDES USA
29/04/2026
Pages